Abstract
Cancer Biotherapy & RadiopharmaceuticalsVol. 36, No. 6 RetractionsOpen AccessRetraction of: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway (doi: 10.1089/cbr.2017.2386)This article retracts the following:Retracted: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling PathwayPublished Online:23 Jul 2021https://doi.org/10.1089/cbr.2017.2386.retractAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Cancer Biotherapy and Radiopharmaceuticals officially retracts the paper entitled, “MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway,” by Hong Dai, Chunmei Wang, Zhihai Yu, Donglin He, Kun Yu, Yin Liu, and Sheng Wang (Cancer Biother Radiopharm 2018;33(3):103–109. doi: 10.1089/cbr.2017.2386) due to the authors' admission that the paper was submitted by a paper mill. A message from the corresponding author reads as follows: “I'm very sorry to tell you that some of the experiments in this paper were delegated to an outsourced laboratories inc. because the experimental conditions are limited in our affiliation. The terrible thing is that the laboratories inc. has been found out experimental misconduct. Unfortunately, our paper is involved in. We have to apply for withdrawal of this paper, which is also under investigation of our affiliation.” [sic]The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves and does not tolerate any violations of scientific misconduct.FiguresReferencesRelatedDetailsRelated articlesRetracted: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway1 Apr 2018Cancer Biotherapy & Radiopharmaceuticals Volume 36Issue 6Aug 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Retraction of: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway (doi: 10.1089/cbr.2017.2386).Cancer Biotherapy and Radiopharmaceuticals.Aug 2021.535-535.http://doi.org/10.1089/cbr.2017.2386.retractcreative commons licensePublished in Volume: 36 Issue 6: July 23, 2021PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
